WOCKPHARMA Wockhardt Ltd Product Launches Announcement 2025 - Successful Treatment Wockhardt Ltd announced the successful treatment of a 15-year-old US patient with Acute Myeloid Leukemia, who was cured of a severe infection after using the antibiotic Zaynich (Zidebactam/Cefepime, WCK 5222), marking the third US patient effectively treated with this drug..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd